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Causes of unplanned interruption of radiotherapy*
Causas de interrupção não-programadas da radioterapia
Sylvia Suelotto Diegues1, Rozana Mesquita Ciconelli2, Roberto Araujo Segreto3
OBJECTIVE: To evaluate the occurrence and causes of unplanned interruption of radiotherapy. MATERIALS
AND METHODS: Retrospective study developed in the Division of Radiotherapy of Hospital Alemão Oswaldo
Cruz in São Paulo, SP, Brazil, with data collected from 560 dossiers of patients submitted to radiotherapy in
the period between January 1, 2005 and December 31, 2005. Chi-squared and Student t tests were utilized
in the data analysis, and p < 0.05 was considered as statistically significant. RESULTS: Interruption of
treatment was identified in 350 cases, corresponding to 62.5% of the patients. The reasons for treatment
interruption were the following: preventive device maintenance (55%), patient’s own private reasons (13%),
adverse reactions to the treatment or to combined radiotherapy/chemotherapy (6%), clinical worsening (3%),
two or more combined reasons (23%). The interruption time interval ranged between 1 and 24 days (mean
1.4 day). One-day interruption was mostly due to preventive device maintenance (84.4%); two–five-day
interruption was due to combined reasons (48.28%). CONCLUSION: The most frequent cause of interruption
was preventive device maintenance, with maximum two-day time interval.
Keywords: Radiotherapy; Cancer; Interruptions; Treatment.
OBJETIVO: Avaliar a ocorrência e as causas de interrupção não-programadas da radioterapia. MATERIAIS E
MÉTODOS: Estudo retrospectivo realizado no Serviço de Radioterapia do Hospital Alemão Oswaldo Cruz, na
cidade de São Paulo, SP. Os dados foram obtidos dos prontuários dos 560 pacientes submetidos a radiote-
rapia, de 1º de janeiro de 2005 a 31 de dezembro de 2005. Os dados foram analisados pelos testes qui-
quadrado e t Student, e os valores de p < 0,05 foram considerados com significância estatística. RESULTA-
DOS: Foram identificados 350 pacientes que interromperam seus tratamentos, o que representou 62,5% do
total da amostra. Os motivos foram: manutenção do aparelho (55%), motivos particulares dos pacientes
(13%), reações do tratamento ou da associação com quimioterapia (6%), piora clínica (3%), associação de
motivos (23%). O intervalo de tempo de interrupção variou de 1 a 24 dias, com média geral de 1,4 dia. Na
interrupção de um dia a maior incidência foi ocasionada pela manutenção (84,4%); de dois a cinco dias a
interrupção foi causada pela associação de motivos (48,28%). CONCLUSÃO: A causa mais freqüente de
interrupção encontrada foi a manutenção preventiva e seu intervalo máximo foi de dois dias.
Unitermos: Radioterapia; Câncer; Interrupções; Tratamento.
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increasing survival rates and better quality
of life for patients considered as incur-
able(1).
Currently, radiotherapy is considered as
the most effective curative treatment after
surgery for cancer. About one third of the
population will develop the disease, and
will require this therapeutic modality, and
60% of the patients will be submitted to
radiotherapy for curative purposes, often
combined with surgery and chemother-
apy(2).
Studies in the literature have evidenced
the influence of the total duration of the
treatment on the local management of the
disease. Such studies suggest that this in-
fluence occurs not only in cases of patients
receiving radical therapy (exclusively ra-
diotherapy), but also in cases of patients
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INTRODUCTION
The combination of early diagnosis and
current therapeutic methods (radiotherapy,
chemotherapy, surgery and bone marrow
transplant) has allowed the achievement of
0100-3984 © Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
receiving adjuvant radiotherapy or com-
bined radiotherapy/brachytherapy(3,4). The
unplanned increase in the total radio-
therapy duration may cause alteration in the
local management of the disease reducing
cure rates(5).
Most of times, conventional treatments
with radiotherapy are delivered in five
weekly fractions of 1.8 Gy to 2.0 Gy
throughout an uninterrupted variable pe-
riod of two-eight weeks, depending on the
disease to be treated; however, alterations
in the therapeutic scheme may occur, like
in cases of accelerated fractioning (1.8 Gy
to 2.0 Gy in two or three fractions/day, with
the same total dose in half of time, hyper-
fractioning (1.1 Gy to 1.2 Gy in two or three
fractions/day), hypofractioning (two or
three fractions/week). The fractioning is
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aimed at allowing the normal cells recov-
ery after each fraction delivery(6).
In the conventional fractioning for treat-
ment of head and neck tumors, intervals of
approximately one week are associated
with a 10%–12% reduction in the local
management of the disease(7). Treatment
delay, planned or unplanned radiotherapy
gap, resulting in extension of the total treat-
ment duration, represent relevant factors
affecting the management of the disease(8).
Variations in the indication for treat-
ment, as adjuvant, radical or palliative ra-
diotherapy, also define different variables
in the influence exerted by the above-men-
tioned factors. Failures in the sequence of
five weekly fractions are defined as inter-
ruptions, provided they are not planned by
the radiotherapist, while weekends are con-
sidered as part of the five-weekly-fraction
scheme with a two-day interval, not being
considered as interruptions(9).
The effects from radiotherapy interrup-
tion on the treatment outcomes in head and
neck tumors are widely known(8). Studies
in the literature(3,4) report the negative ef-
fects from radiotherapy interruption.
Adverse effects from the extension of
the total treatment duration as a result of
radiotherapy interruption also have been
observed in cases of postoperative radio-
therapy where intervals of > 10 days re-
sulted in a 10% to 20% decrease in the five-
year survival rate(7).
Videtic et al.(10) have analyzed the radio-
therapy interruption effect on patients with
small cell lung cancer treated with com-
bined radiotherapy/chemotherapy, and con-
cluded that this gap, even if utilized to
minimize adverse side effects, affected the
local management of the disease and re-
duced the survival of these patients.
Chen et al.(11) have found results indi-
cating a 9% decrease in the rate of disease-
free survival in patients with non-small cell
lung cancer who had extended their over-
all treatment time for one week because of
unplanned interruptions during radio-
therapy.
Perez et al.(12) have reported that pa-
tients with stage T2 prostate cancer pre-
sented pelvic failures and poorer responses
when the overall treatment time was > 9
weeks, as compared with those who com-
pleted the treatment in less time; however,
worsening of the response has not been
evidenced in patients treated with doses >
72 Gy.
Maciejewski & Majewski(13) have
evaluated patients with invasive bladder
cancer, reporting that the prolongation of
the overall treatment time from 40 to 55
days reduces the rate of local management
from 50% to 5%.
According to the “Guidelines for the
management of a radical unscheduled in-
terruption or prolongation of a radical
course of radiotherapy”(14), studies demon-
strate that the minimum interruption inter-
val which may significantly affect the treat-
ment outcome is around two days; although
these guidelines also mention that any in-
terruption resulting in prolongation of the
overall treatment time is potentially hazard-
ous; these studies also report that interrup-
tions occur in more than 30% of treatments.
According to the mentioned Guide-
lines(14), the causes of treatment interrup-
tions may be considered as follows: a) the
foreseeable causes, i.e., those scheduled or
previously known — preventive equipment
maintenance, local and national public
holidays, specific treatment schemes with
only two or three weekly fractions, and
non-overlapping treatment in cases of com-
bined teletherapy/brachytherapy; b) the un-
foreseeable ones, i.e., those unscheduled
— occurring because of the treatment tox-
icity (acute effects of the treatment), espe-
cially in cases of combined radiotherapy/
chemotherapy, clinical intercurrences,
equipment breakdown, and also patients´
private reasons.
At the level of institutions, the most fre-
quent interruptions occur because of
planned preventive equipment mainte-
nance, equipment breakdown and public
holidays.
Studies(3,4,7,14) approach the methods
utilized to counterbalance the interruptions
effects, however, a consensus on this issue
is still to be reached.
According to Dale et al.(3), interrupted
treatments should be individually analyzed,
considering the absence of an universal
method to solve all the resulting problems.
Once the interruption has occurred, it is
necessary to determine the number of
missed fractions, and try to complete the
treatment within the previously determined
period (treating the patient twice a day or,
alternatively, continuing the treatment over
a weekend). Another alternative is to intro-
duce an altered fractionation schedule to
compensate the interruptions. The qua-
dratic-linear model currently prevails in the
field of radiobiology(15), but this topic is not
under the scope of the present study.
The present study was aimed at evalu-
ating the occurrence and causes of un-
planned radiotherapy interruptions, and
analyzing the reasons and interruption time
intervals.
MATERIALS AND METHODS
The present retrospective study was
developed in the Department of Radio-
therapy at Hospital Alemão Oswaldo Cruz,
in the city of São Paulo, SP, Brazil. Data
were collected from the dossiers of 560
patients submitted to radiotherapy in the
period between January 1st and December
31st, 2005. This center assists private/
health insurance patients (public health
system patients excluded) in the hospital/
hospital-day and in other institutions. All
of the patients underwent treatment in a 6
MV Varian (Clinac) linear accelerator. The
moments of the interruptions along the
treatments were not analyzed in the present
study.
Weekends and public holidays were
excluded from the analysis, and were not
considered as interruptions for the pur-
poses of the present study. However, in
cases of public holydays falling near a
weekend, with a working day between
them, this working day without treatment
was considered as an interruption.
Variables evaluated were the following:
sex, age, International Disease Code (IDC),
combined radiotherapy/chemotherapy,
presence of absence of treatment interrup-
tion in consecutive days or not, and, in case
of presence of interruption, classification
into 1–5-day intervals, 6–15-day intervals
or more-than-16-day intervals. Reasons for
these interruptions also were taken into
consideration.
The reasons for treatment interruption
were classified into treatment effects, clini-
cal worsening as a result of the disease and
not of the treatment, patients’ private rea-
sons, preventive equipment maintenance,
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equipment breakdown, and also a combi-
nation of reasons, when two or more of the
previously mentioned reasons caused treat-
ment interruption.
Data were tabulated and entered into an
Excel worksheet, and statistically analyzed
by means of chi-squared and t-Student
tests, with values corresponding to p < 0.05
being considered as statistically signifi-
cant.
RESULTS
In a sample of 560 patients included in
the present study, 261 were men, and 299,
women, with ages ranging from 5 to 94
years (mean = 58 years, standard deviation
= 9); statistical differentiation of sex was
not taken into consideration. In the analy-
sis of ages, patients with > 40 years repre-
sented 86.5% of the whole sample.
The IDC was redistributed according to
tumors localization, independently from
their staging: breast, 201 patients (36%);
abdomen and pelvis, 112 patients (20%);
prostate, 106 patients (19%); chest, 79 pa-
tients (14%); and other types (11%), which
will not be described because of their low
incidence; breast and prostate tumors were
separately analyzed, considering their
higher incidence as compared with the
others.
As regards radiotherapy interruption,
350 patients who interrupted their treat-
ment were identified in the present study,
representing 62.5% of the sample. The rea-
sons for interruptions were classified into
five different types according to the recom-
mendations included in to previously men-
tioned Guidelines(14) (Table 1).
The patients presenting combined rea-
sons for treatment interruption were reclas-
sified as to determining the types of reasons
for such interruptions. Seventy-one of
these patients, corresponding to 89.9%, had
their radiotherapy interrupted because of
preventive equipment maintenance.
As regards interruption time interval,
the patients were divided into three groups
— one-day interruption, two–five-day in-
terruption and six or more days of interrup-
tion — with the respective reasons for these
interruptions (Table 2).
Most frequently, one-day-interruptions
were caused by preventive equipment main-
tenance (84.41%); on the other hand, none
of the six-day interruptions (0%) was caused
by preventive equipment maintenance.
The interruption time interval ranged
from one to 24 days (mean = 1.4, standard
deviation = 9.5) Table 3).
The low average of days (1.2 days)
without treatment because of preventive
equipment maintenance is the evidence of
an appropriate quality control, avoiding
extended periods without treatment caused
by equipment breakdown.
Two groups of patients who has pre-
sented treatment interruptions were statis-
tically analyzed by means of the chi-
squared test: the first group included all the
patients who had their treatment inter-
rupted because of equipment maintenance,
and the second one, for other reasons, dem-
onstrating statistical significance (p =
0.000000010).
The result of the statistical analysis of
the interruption time interval, also demon-
strated statistical significance in the com-
parison between these same groups [equip-
ment maintenance (1.73) versus other rea-
sons (3.85)], i.e., the patients remained
without treatment for longer periods be-
cause of other reasons than for equipment
maintenance (t Student average of mainte-
nance days versus other reasons: p =
0.0000000063).
Statistical significance also was found
as a result of the comparison between the
mean interruption time interval because of
clinical worsening (8.42 days) versus pa-
tients’ private reasons: p = 0.014680042).
The analysis of the mean interruption
time interval related to reactions to the
treatment (5.8) versus patients’ private rea-
sons (1.8) also demonstrated statistical
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significance, corroborating the relevance
of treatment side effects when the patients’
adherence to the treatment is considered (t
Student average reaction to the treatment
days versus patients’ private reasons: p =
0.000982904).
No statistical significance was found in
the sample of the present study in the com-
parison between the groups of patients with
reactions to the treatment (5.8 days) and
clinical worsening (8.42 days), probably
because of the low number of patients in-
cluded in these groups (t Student test –
mean number of days – reaction to treat-
ment versus clinical worsening: p =
0.310165484).
DISCUSSION
This is the first Brazilian study evalu-
ating the causes of unplanned interruption
of radiotherapy.
James et al.(16), in a national audit study
about head & neck cancer developed in the
United Kingdom, have evaluated the man-
agement of treatment interruptions in 55
radiotherapy centers, and have found a rate
of interruption of 55% corresponding to
1,506 of 2,553 patients who have inter-
rupted their treatments; however, when
extended treatment period (one additional
day) was taken into consideration, the mean
interruption rate increased to 73%.
Duncan et al.(17) have reported 68.9% of
cases of treatment interruption in their
study with 383 patients with larynx cancer.
Erridge et al.(18) have found 425 patients
(66%) who had interrupted their treatment
with external and intracavitary radio-
therapy for uterine cervix cancer.
The “Guidelines for the management of
a radical unscheduled interruption or pro-
longation of a radical course of radiother-
apy”(14) reported 66% of treatment interrup-
tion in cases of patients with laryngeal tu-
mors.
Bese et al.(9), in the first study evaluat-
ing the effects from treatment interruptions
in 853 patients with breast cancer have
found 87% of them who had interrupted
their treatment.
González San Segundo et al.(8) remark
the scarcity of studies evaluating treatment
interruptions incidence.
In the present study concerning the oc-
currence of treatment interruption, 350
patients (62.5%) had their treatment inter-
rupted for at least one day.
No other similar study evaluating a
whole sample of patients was found in the
literature, but interruption rates similar to
other studies were found, corroborating the
correctness of the methodology utilized in
the present study.
In the present study, the reasons for
treatment interruption were classified ac-
cording the above mentioned Guidelines(14)
(preventive equipment maintenance, repre-
senting 61% of reasons for treatment inter-
ruption, followed by unexpected equip-
ment breakdown with 19%, reactions to
treatment with 14%, and finally, patient’s
private reason with 6%).
In addition, in the present study, equip-
ment maintenance (55%) represented the
main reason for treatment interruption, fol-
lowed by patient’s private reasons (13%)
and reactions to the treatment itself or to
combined radiotherapy/chemotherapy
(6%). The interruption rate for reasons of
clinical worsening was the lowest (3%).
In the present study, combined reasons
(two or more reasons causing the interrup-
tion) presented a 23% incidence, but cor-
relate studies were not found among those
reviewed.
The results of the present analysis were
statistically significant, demonstrating the
impact of the preventive equipment main-
tenance on the incidence of treatment in-
terruptions.
The interruption time interval ranged
between one and 24 days (mean = 1.4 day).
Studies reviewed(5,17,19,20) on cases of
head and neck cancer suggest that an un-
scheduled one-day interruption may result
in 1.4% absolute decrease in the local man-
agement of the disease; on the other hand,
about seven days of interruption in the
treatment may cause a decrease in the lo-
cal management of the disease ranging
between 3% and 25%, adversely affecting
the response to the therapy. However, these
studies have shown to be inconclusive as
for the phase of the treatment where the
interruptions occurred (e.g., early, middle
or later phases)(5,14).
Most frequently (84.4%), one-day inter-
ruptions occurred because of equipment
maintenance, followed by patients’ private
reasons (13.9%); 48.28% of 2–5-day inter-
ruptions occurred because of combined
reasons, and in 89.9% of these cases, one of
the reasons was equipment maintenance;
42.11% of 6-or-more-day interruptions
were caused by reactions to the treatment
and none (0%) by equipment maintenance,
demonstrating an appropriate quality con-
trol, avoiding extended periods without
treatment because of equipment breakdown.
Suwinski et al.(5) reports that intervals
of less than five days do not affect the in-
cidence of disease recidivation, and recom-
mends that, in cases where interruptions
cannot be avoided, it should at least have
its time interval reduced.
Bese et al.(9), in a study evaluating the
effect of the treatment interruption in cases
of breast cancer, report that they have not
found adverse effects resulting from less-
than-seven-day interruptions; on the other
hand, in cases where the interruption du-
ration was longer, they have found about
5% decrease in the local management of
the disease.
Considering the different characteristics
of the present study, the effects from treat-
ment interruptions were not evaluated, but
it is important to note that the average num-
ber of interruptions was relatively low.
Radiotherapy centers should accom-
plish periodical preventive equipment
maintenance at least every three months, in
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order to guarantee good quality assistance
to patients, avoiding frequent equipment
breakdowns that would contribute for more
frequent and longer interruptions.
González San Segundo et al.(8) highlight
the unquestionable necessity of quality
control programs in radiotherapy centers,
including dosimetric controls and preven-
tive equipment maintenance with an appro-
priate periodicity to avoid that patients are
submitted to treatment interruptions with-
out any scientific grounds or evidence of
effectiveness and safety.
According to Calcina et al.(21), radio-
therapy centers should schedule funda-
mental and essential quality control tests
for all of their equipment as necessary and
according to their availability, assuring an
appropriate treatment to the patients. Steps
towards the management of treatment in-
terruptions or extensions are described in
the “Guidelines for the management of a
radical unscheduled interruption or prolon-
gation of a radical course of radiotherapy”(14)
recommending an appropriate provision of
human and physical resources (infrastruc-
ture), as well as the transference of the
patient to another equipment in case of
equipment maintenance or breakdown.
The following considerations should be
taken into account:
– How many Brazilian radiotherapy
centers could count on two radiotherapy
apparatuses?
– If any, not always these apparatuses
are technically similar, i.e. with different
energies.
– How could the patients be transferred
during equipment maintenance?
– Would it be actually feasible, consid-
ering that frequently there is a waiting time
for treatment as a result from resources
(equipment) scarcity?
– Would it be worthwhile to schedule
equipment maintenance on weekends?
In Brazil, the monthly cost for preven-
tive equipment maintenance on working
days reaches US$ 2,500. In case of equip-
ment maintenance on weekends, this cost
increases to about US$ 3,500.
An study developed by Giessen et al.(22)
reports annual values of about US$ 3,000
to US$ 91,740 (mean = US$ 41,390) for
maintenance of linear accelerators (includ-
ing spare parts).
The daily income generated by a linear
accelerator is US$ 1,800 corresponding to:
the cost per field (R$ 0.27) according to the
AMB Table (Brazilian Medical Associa-
tion), for 60 patients/day (12 equipment-
hours/day × five patients/hour) with 2.5
fields per patient, on average. As a result,
preventive equipment maintenance on
weekends, is financially unfeasible.
Treatment interruptions occurring as a
result of holidays, equipment breakdowns,
or for social reasons used to be more eas-
ily accepted in the past as a function of the
unawareness of tumors treatment methods
and radiobiology(8), when the concepts of
cumulative effects and standard dose were
widely disseminated as mechanisms for
counterbalancing treatment interruptions.
Presently, new methods corroborate the
effective biological effects as the best
methods for counterbalancing interrup-
tions, especially those with longer inter-
vals(3,7,16,18).
The mentioned Guidelines(14) also rec-
ommend avoiding extended treatment in-
terruptions.
In Brazil, some centers close for four to
five consecutive days because of bridged
holidays. Unfortunately, this practice is
extremely frequent, especially when a holi-
day falling on a Wednesday causes the cen-
ter to remain closed up to the next Monday,
and these bridged days are not paid.
Additionally, efforts should be under-
taken to improve the management of the
reactions to the treatment and, conse-
quently, reduce the risk for long treatment
intervals.
For this purpose, patients should receive
multiprofessional assistance not only from
the radiotherapist but also from specialized
nurses, nutritionists, dentists and others to
minimize possible reactions to the treat-
ment. Early in the treatment, guidance
manuals should be given by nurses to the
patients(23), facilitating the patients’ adher-
ence to the treatment.
Chen et al.(24), studying the causes of
radiotherapy interruption in patients with
nasopharyngeal carcinoma, reported that
the patients who underwent pretreatment
nursing consultation presented lower rates
of treatment interruption because they
could better withstand the side effects.
Considering the complexity of this
theme, further, deeper studies in other ra-
diotherapy centers are required to validate
the methodology utilized, allowing the
implementation in Brazil of guidelines re-
garding the management of treatment inter-
ruptions.
No other similar study if found in the
literature evaluating a whole sample of
patients, however similar rates of interrup-
tion were found in other studies, corrobo-
rating the correctness of the methodology
utilized in the present study.
In conclusion, the most frequent cause
of interruption is preventive device main-
tenance, with maximum two-day time in-
terval.
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